Today's show was recorded July 1st, the first day that Vermont’s GMO labeling law went into effect. Just how big a win was this for the anti-GMO crowd, we ask our two commentators, Nathan Pearson and Laura Hercher. They have a surprisingly optimistic take, suggesting that the GMO labeling could become a positive marketing tool.
Laura says the scale and ease of CRISPR vs the older technology of zinc fingers is like going from manuscript writing to the printing press. She insists, therefore, that the approval of the first ever CRISPR trial is a big deal even though we’ve already been doing the same cell replacement therapy with zinc fingers. She also points out that the new trial is funded by Sean Parker’s foundation which is moving along at a Silicon Valley pace.
"The tech industry has never had their moment where it killed someone to move too fast.”
Last week the Supreme Court killed off Sequenom’s patent for prenatal screening. After Laura and Theral hotly debate whether there should be such patents, Nathan suggests there is a right balance.
“It’s sort of like tuning a carburetor,” he says. "Patents can encourage people to invest, but they can also inhibit the development of technology.”
And lastly, DNA has a new mascot. It’s called the SmidgIon.